103 related articles for article (PubMed ID: 20956280)
21. Phosphoinositide 3-kinase is not overexpressed in melanocytic lesions.
Singh RS; Diwan AH; Zhang PS; Prieto VG
J Cutan Pathol; 2007 Mar; 34(3):220-5. PubMed ID: 17302605
[TBL] [Abstract][Full Text] [Related]
22. Prognostic relevance of P-cadherin expression in melanocytic skin tumours analysed by high-throughput tissue microarrays.
Bauer R; Wild PJ; Meyer S; Bataille F; Pauer A; Klinkhammer-Schalke M; Hofstaedter F; Bosserhoff AK
J Clin Pathol; 2006 Jul; 59(7):699-705. PubMed ID: 16565225
[TBL] [Abstract][Full Text] [Related]
23. Distinction of conjunctival melanocytic nevi from melanomas by fluorescence in situ hybridization.
Busam KJ; Fang Y; Jhanwar SC; Pulitzer MP; Marr B; Abramson DH
J Cutan Pathol; 2010 Feb; 37(2):196-203. PubMed ID: 20100177
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA Profiling in Benign and Malignant Conjunctival Melanocytic Lesions.
van Ipenburg JA; Gillis Ing AJM; Dorssers LCJ; van den Bosch QCC; van Ginderdeuren R; Missotten GS; Naus N; Paridaens D; Looijenga LHJ; Verdijk RM
Ophthalmology; 2020 Mar; 127(3):432-434. PubMed ID: 31767433
[No Abstract] [Full Text] [Related]
25. Increased expression of germinal center-associated nuclear protein (GANP) is associated with malignant transformation of melanocytes.
Kageshita T; Kuwahara K; Oka M; Ma D; Ono T; Sakaguchi N
J Dermatol Sci; 2006 Apr; 42(1):55-63. PubMed ID: 16431081
[TBL] [Abstract][Full Text] [Related]
26. [Distribution of melanoma-associated antigens (HMB 45 and S 100) in benign and malignant melanocytic tumors of the conjunctiva].
Steuhl KP; Rohrbach JM; Knorr M
Klin Monbl Augenheilkd; 1991 Sep; 199(3):187-91. PubMed ID: 1753671
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of the mTOR pathway in ocular (uvea and conjunctiva) melanoma.
Pópulo H; Soares P; Rocha AS; Silva P; Lopes JM
Melanoma Res; 2010 Apr; 20(2):107-17. PubMed ID: 20173664
[TBL] [Abstract][Full Text] [Related]
28. [Malignant conjunctival melanoma. Clinical review with recommendations for diagnosis, therapy and follow-up].
Lommatzsch PK; Werschnik C
Klin Monbl Augenheilkd; 2002 Oct; 219(10):710-21. PubMed ID: 12447715
[TBL] [Abstract][Full Text] [Related]
29. Insulin-like growth factor-I receptor and PTEN protein expression in endometrial carcinoma. Correlation with bax and bcl-2 expression, microsatellite instability status, and outcome.
Peiró G; Lohse P; Mayr D; Diebold J
Am J Clin Pathol; 2003 Jul; 120(1):78-85. PubMed ID: 12866376
[TBL] [Abstract][Full Text] [Related]
30. PTEN expression is a strong predictor of survival in mesothelioma patients.
Opitz I; Soltermann A; Abaecherli M; Hinterberger M; Probst-Hensch N; Stahel R; Moch H; Weder W
Eur J Cardiothorac Surg; 2008 Mar; 33(3):502-6. PubMed ID: 18248818
[TBL] [Abstract][Full Text] [Related]
31. Usefulness of a red chromagen in the diagnosis of melanocytic lesions of the conjunctiva.
Jiang K; Brownstein S; Lam K; Burns B; Farmer J
JAMA Ophthalmol; 2014 May; 132(5):622-9. PubMed ID: 24626521
[TBL] [Abstract][Full Text] [Related]
32. Pten deficiency in melanocytes results in resistance to hair graying and susceptibility to carcinogen-induced melanomagenesis.
Inoue-Narita T; Hamada K; Sasaki T; Hatakeyama S; Fujita S; Kawahara K; Sasaki M; Kishimoto H; Eguchi S; Kojima I; Beermann F; Kimura T; Osawa M; Itami S; Mak TW; Nakano T; Manabe M; Suzuki A
Cancer Res; 2008 Jul; 68(14):5760-8. PubMed ID: 18632629
[TBL] [Abstract][Full Text] [Related]
33. Expression of p53 in conjunctival melanocytic nevi. An immunohistochemical study.
Jay V; Ho M; Hunter W; Rootman D; Zielenska M
Arch Pathol Lab Med; 1996 Apr; 120(4):378-9. PubMed ID: 8619750
[TBL] [Abstract][Full Text] [Related]
34. [Inflammatory juvenile conjunctival nevus (IJCN)].
Lommatzsch PK; Willerding G; Nenning H; Taubert G
Klin Monbl Augenheilkd; 2007 May; 224(5):422-6. PubMed ID: 17516373
[TBL] [Abstract][Full Text] [Related]
35. Bcl-2 expression in human melanocytes and melanocytic tumors.
van den Oord JJ; Vandeghinste N; De Ley M; De Wolf-Peeters C
Am J Pathol; 1994 Aug; 145(2):294-300. PubMed ID: 8053490
[TBL] [Abstract][Full Text] [Related]
36. Pigmentation of conjunctival melanoma recurrences and outcome.
Brouwer NJ; Marinkovic M; Luyten GPM; Shields CL; Jager MJ
Graefes Arch Clin Exp Ophthalmol; 2019 Aug; 257(8):1783-1788. PubMed ID: 31098751
[TBL] [Abstract][Full Text] [Related]
37. Conjunctival Melanoma: Genetic and Epigenetic Insights of a Distinct Type of Melanoma.
Rossi E; Schinzari G; Maiorano BA; Pagliara MM; Di Stefani A; Bria E; Peris K; Blasi MA; Tortora G
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31683701
[TBL] [Abstract][Full Text] [Related]
38. Bilateral conjunctival melanocytic nevi of simultaneous onset simulating conjunctivitis in a child.
Jakobiec FA; Sandhu H; Bhat P; Colby K
Cornea; 2010 Aug; 29(8):937-40. PubMed ID: 20508514
[TBL] [Abstract][Full Text] [Related]
39. G1 cell cycle regulators in congenital melanocytic nevi. Comparison with acquired nevi and melanomas.
Stefanaki C; Stefanaki K; Antoniou C; Argyrakos T; Stratigos A; Patereli A; Katsambas A
J Cutan Pathol; 2008 Sep; 35(9):799-808. PubMed ID: 18494826
[TBL] [Abstract][Full Text] [Related]
40. Heat shock protein expression in human gliomas.
Strik HM; Weller M; Frank B; Hermisson M; Deininger MH; Dichgans J; Meyermann R
Anticancer Res; 2000; 20(6B):4457-62. PubMed ID: 11205288
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
